Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Neue β‑Laktam-Antibiotika und β‑Laktamase-Inhibitoren gegen multiresistente Gram-negative Erreger
Translated title of the contribution
:
New β‑lactam antibiotics and β‑lactamase inhibitors against multidrug-resistant Gram-negative bacteria
Alexander Mischnik
*
, Christoph Lübbert, Nico T. Mutters
*
Corresponding author for this work
Clinic of Infectious Diseases and Microbiology
Fachbereich Infektions- und Tropenmedizin
University of Leipzig
University of Freiburg
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New β‑lactam antibiotics and β‑lactamase inhibitors against multidrug-resistant Gram-negative bacteria'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Beta Lactam Antibiotic
100%
Penicillinase
100%
Multidrug-Resistant Gram-Negative Bacteria
100%
Avibactam
50%
Aminoglycoside
25%
Meropenem
25%
Aztreonam
25%
Cilastatin
25%
Macrolide
25%
Imipenem
25%
Ketolide
25%
Tazobactam
25%
Cefiderocol
25%
Vaborbactam
25%
Polymyxin
25%
Relebactam
25%
Medicine and Dentistry
Multidrug-Resistant Gram-Negative Bacteria
100%
β-Lactam antibiotic
100%
Avibactam
50%
Cefiderocol
25%
Ketolide
25%
Imipenem/Cilastatin
25%
Tazobactam
25%
Vaborbactam
25%
Relebactam
25%
Polymyxin
25%
Aminoglycoside
25%
Aztreonam
25%